A molecular analysis led to the conclusion that punicalagin caused increased expression and levels of mRNA VEGF and downregulation of expression of vascular endothelial growth factor receptor-1/fms-like tyrosine kinase-1, suggesting that punicalagin has a positive effect on angiogenic balance during experimental preeclampsia [13]. This evidence concerns the gene FLT1 and preeclampsia.